Profil
Danny Robert Hegglin served as a Non-Executive Director at Realm Therapeutics Plc from 2013 to 2017 and as a Partner at TT International (Hong Kong) Ltd.
from 2009 to 2013.
Anciens postes connus de Danny Robert Hegglin
| Sociétés | Poste | Fin |
|---|---|---|
| REALM THERAPEUTICS PLC | Directeur/Membre du Conseil | 17/11/2017 |
TT International (Hong Kong) Ltd.
 TT International (Hong Kong) Ltd. Investment ManagersFinance TT International (Hong Kong) Ltd. (TT-Hong Kong) is the alternative investment management subsidiary of Great Britain-based TT International Asset Management Ltd., which was acquired in 2020 by Sumitomo Mitsui Financial Group, Inc. (TYO: 8316) in Japan. Headquartered in Hong Kong, TT-Hong Kong was founded in 2004 to manage long/short Asian equities and hedge fund products, primarily for sophisticated institutional investors. | President | 01/01/2013 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
TT International (Hong Kong) Ltd.
TT International (Hong Kong) Ltd. Investment ManagersFinance TT International (Hong Kong) Ltd. (TT-Hong Kong) is the alternative investment management subsidiary of Great Britain-based TT International Asset Management Ltd., which was acquired in 2020 by Sumitomo Mitsui Financial Group, Inc. (TYO: 8316) in Japan. Headquartered in Hong Kong, TT-Hong Kong was founded in 2004 to manage long/short Asian equities and hedge fund products, primarily for sophisticated institutional investors. | Finance |
Realm Therapeutics Plc
 Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA. | Health Technology |